FDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.

The system is structured around a client-server architecture designed to provide scalability, remote accessibility, and ...

Cardiologists use echocardiography to diagnose a range of functional or structural abnormalities of the heart. Using more ...

Oncology Trials with AI Imaging Biomarkers Companies will provide enhanced tools for early response detection, smarter patient stratification, and the prediction of oncology treatment outcomes ...

Artificial intelligence (AI) has the potential to uncover valuable insights hidden in protocols and clinical study reports across the pharmaceutical industry, according to experts at the ...

IQVIA’s new AI orchestrator agents — powered by IQVIA Connected Intelligence and NVIDIA AI Foundry — speed clinical trials and pharmaceutical commercialization workflows to bring therapies to patients ...

Potential of Gen AI in clinical trials acceleration The process of developing a new drug can take up to 12 years and cost an estimated $2.3 billion , and yet 90% of clinical trials fail.

While retrieval augmented generations (RAGs) and agents grab attention, what’s next is really a search across your data.

Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...

Industry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence's role in transforming clinical trials.

Traditional clinical trial challenges – patient recruitment, retention and data quality – are being transformed through AI-powered solutions. One approach is to use ‘digital twin’ technology – ...

In a major breakthrough, a team of researchers from The City College of New York and Memorial Sloan Kettering Cancer Center ...